256 related articles for article (PubMed ID: 27036110)
1. The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.
Tamir A; Gangadharan A; Balwani S; Tanaka T; Patel U; Hassan A; Benke S; Agas A; D'Agostino J; Shin D; Yoon S; Goy A; Pecora A; Suh KS
J Ovarian Res; 2016 Mar; 9():20. PubMed ID: 27036110
[TBL] [Abstract][Full Text] [Related]
2. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
[TBL] [Abstract][Full Text] [Related]
3. Prostasin, a potential tumor marker in ovarian cancer--a pilot study.
Costa FP; Batista EL; Zelmanowicz A; Svedman C; Devenz G; Alves S; Silva AS; Garicochea B
Clinics (Sao Paulo); 2009; 64(7):641-4. PubMed ID: 19606239
[TBL] [Abstract][Full Text] [Related]
4. Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
Tamir A; Jag U; Sarojini S; Schindewolf C; Tanaka T; Gharbaran R; Patel H; Sood A; Hu W; Patwa R; Blake P; Chirina P; Oh Jeong J; Lim H; Goy A; Pecora A; Suh KS
J Ovarian Res; 2014 Dec; 7():109. PubMed ID: 25477184
[TBL] [Abstract][Full Text] [Related]
5. Co-localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptase.
List K; Hobson JP; Molinolo A; Bugge TH
J Cell Physiol; 2007 Oct; 213(1):237-45. PubMed ID: 17471493
[TBL] [Abstract][Full Text] [Related]
6. Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT).
Chen LM; Verity NJ; Chai KX
BMC Cancer; 2009 Oct; 9():377. PubMed ID: 19849847
[TBL] [Abstract][Full Text] [Related]
7. Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer.
Lee JH; Kim YH; Kim KH; Cho JY; Woo SM; Yoo BC; Kim SC
Cancer Res Treat; 2018 Jul; 50(3):883-893. PubMed ID: 28934848
[TBL] [Abstract][Full Text] [Related]
8. The membrane-anchored serine protease prostasin (CAP1/PRSS8) supports epidermal development and postnatal homeostasis independent of its enzymatic activity.
Peters DE; Szabo R; Friis S; Shylo NA; Uzzun Sales K; Holmbeck K; Bugge TH
J Biol Chem; 2014 May; 289(21):14740-9. PubMed ID: 24706745
[TBL] [Abstract][Full Text] [Related]
9. Sodium retention in nephrotic syndrome is independent of the activation of the membrane-anchored serine protease prostasin (CAP1/PRSS8) and its enzymatic activity.
Essigke D; Bohnert BN; Janessa A; Wörn M; Omage K; Kalbacher H; Birkenfeld AL; Bugge TH; Szabo R; Artunc F
Pflugers Arch; 2022 Jun; 474(6):613-624. PubMed ID: 35312839
[TBL] [Abstract][Full Text] [Related]
10. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
[TBL] [Abstract][Full Text] [Related]
11. PSP94, an upstream signaling mediator of prostasin found highly elevated in ovarian cancer.
Ma JX; Yan BX; Zhang J; Jiang BH; Guo Y; Riedel H; Mueller MD; Remick SC; Yu JJ
Cell Death Dis; 2014 Sep; 5(9):e1407. PubMed ID: 25188517
[TBL] [Abstract][Full Text] [Related]
12. Prostasin may contribute to chemoresistance, repress cancer cells in ovarian cancer, and is involved in the signaling pathways of CASP/PAK2-p34/actin.
Yan BX; Ma JX; Zhang J; Guo Y; Mueller MD; Remick SC; Yu JJ
Cell Death Dis; 2014 Jan; 5(1):e995. PubMed ID: 24434518
[TBL] [Abstract][Full Text] [Related]
13. Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma.
McIntosh MW; Liu Y; Drescher C; Urban N; Diamandis EP
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4422-8. PubMed ID: 17671125
[TBL] [Abstract][Full Text] [Related]
14. Relative Quantification and Higher-Order Modeling of the Plasma Glycan Cancer Burden Ratio in Ovarian Cancer Case-Control Samples.
Hecht ES; Scholl EH; Walker SH; Taylor AD; Cliby WA; Motsinger-Reif AA; Muddiman DC
J Proteome Res; 2015 Oct; 14(10):4394-401. PubMed ID: 26347193
[TBL] [Abstract][Full Text] [Related]
15. The role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasis.
Gao L; Cheng HY; Dong L; Ye X; Liu YN; Chang XH; Cheng YX; Chen J; Ma RQ; Cui H
J Int Med Res; 2011; 39(5):1645-60. PubMed ID: 22117965
[TBL] [Abstract][Full Text] [Related]
16. Structure and chromosomal localization of the human prostasin (PRSS8) gene.
Yu JX; Chao L; Ward DC; Chao J
Genomics; 1996 Mar; 32(3):334-40. PubMed ID: 8838796
[TBL] [Abstract][Full Text] [Related]
17. Knocking down Sterol regulatory element binding protein 2 (SREBF2) inhibits the Serine Protease 8 (PRSS8) /sodium channel epithelial 1alpha subunit (SCNN1A) axis to reduce the cell proliferation, migration and epithelial-mesenchymal transformation of ovarian cancer.
Cai C; Zhang Y; Peng X
Bioengineered; 2021 Dec; 12(2):9390-9400. PubMed ID: 34823420
[TBL] [Abstract][Full Text] [Related]
18. In-depth LC-MS/MS analysis of the chicken ovarian cancer proteome reveals conserved and novel differentially regulated proteins in humans.
Nepomuceno AI; Shao H; Jing K; Ma Y; Petitte JN; Idowu MO; Muddiman DC; Fang X; Hawkridge AM
Anal Bioanal Chem; 2015 Sep; 407(22):6851-63. PubMed ID: 26159569
[TBL] [Abstract][Full Text] [Related]
19. A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care.
Shadfan BH; Simmons AR; Simmons GW; Ho A; Wong J; Lu KH; Bast RC; McDevitt JT
Cancer Prev Res (Phila); 2015 Jan; 8(1):37-48. PubMed ID: 25388014
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin as a potential diagnostic biomarker for ovarian cancer.
Kim JH; Skates SJ; Uede T; Wong KK; Schorge JO; Feltmate CM; Berkowitz RS; Cramer DW; Mok SC
JAMA; 2002 Apr; 287(13):1671-9. PubMed ID: 11926891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
